Virginia Cancer Specialists and The US Oncology Network Welcome Breast Surgeon Dr. Hernan Vargas

March 12, 2018

Renowned breast surgeon joins practice with more than two decades of experience, expanding the service offering to more patients Fairfax, Va. (March 12, 2018) —Virginia Cancer Specialists (VCS) announced that Hernan Vargas, MD, has joined the practice. VCS, a practice in The US Oncology Network, is a premier cancer care and research center in Northern […]

Read More

Consultants in Medical Oncology and Hematology Joins The US Oncology Network, Enhancing Its Ability to Deliver High-Quality Care throughout the Greater Philadelphia Area

January 18, 2018

Practice increases clinical trial and advanced treatment options while gaining access to resources that improve operational efficiencies Philadelphia, Pa. (January 18, 2018) – Consultants in Medical Oncology and Hematology (CMOH), a premier provider of comprehensive medical oncology services throughout the Philadelphia region for nearly 30 years and a national leader in the development of patient and […]

Read More

iKnowMed EHR and iKnowMed Generation 2 EHR Receive 2015 ONC-ACB Certification

January 5, 2018

Providers using iKnowMed certified EHR technology are eligible for Quality Performance bonus points under Merit-based Incentive Payment System The Woodlands, Texas (January 5, 2018) — McKesson Specialty Health, an industry leader in services and technologies that advance community-based healthcare, announced that iKnowMedSM electronic health record (EHR) (version 6.8) and iKnowMed Generation 2 EHR (version 3.0) […]

Read More

McKesson and US Oncology Research Announce Schedule of Presentations at the 2017 American Society of Hematology Annual Meeting and Exposition

December 4, 2017

19 abstracts on clinical research conducted by top affiliated investigators are scheduled for presentation The Woodlands, Texas (December 4, 2017) – At the 59th American Society of Hematology Annual Meeting and Exposition (ASH), leading investigators from The US Oncology Network and US Oncology Research will showcase detailed findings from 19 studies (four orals, 14 poster […]

Read More

Virginia Cancer Specialists and The US Oncology Network Welcome Dr. Stephanie Akbari

November 28, 2017

Dr. Akbari, a pioneer in breast cancer surgery, brings new line of treatment services to the clinic Fairfax, Va. (November 28, 2017) —Virginia Cancer Specialists (VCS) announced that Stephanie Akbari, MD, FACS, has joined the practice. VCS, a practice in The US Oncology Network, is a premier cancer care and research center in Northern Virginia […]

Read More

Frederick Oncology & Hematology Associates Joins Maryland Oncology Hematology and The US Oncology Network

November 3, 2017

Affiliation enhances care at both practices, expanding Maryland Oncology Hematology’s services into the Baltimore–Washington Metropolitan Area Columbia, Md. (November 3, 2017) — Maryland Oncology Hematology (MOH), a premier provider of community-based advanced cancer care services throughout the Maryland/Washington D.C. region and an affiliate of The US Oncology Network (The Network), announced that Frederick Oncology & […]

Read More

US Oncology Research Annual Science Forum Focuses on Advances in Clinical Research, Enabling Promising New Treatments for Patients in the Community Setting

November 2, 2017

Organization celebrates enrolling 70,000 patients to clinical trials, contributing to more than 70 FDA cancer therapy approvals The Woodlands, Texas (Nov. 2, 2017) — US Oncology Research is holding its 16th Annual Science Forum on November 2-3 in Dallas, an annual meeting that brings together more than 150 affiliated US Oncology Research physician researchers and […]

Read More

Southern Cancer Center is Global Leader in Kidney Cancer Clinical Trial

September 19, 2017

Mobile, Ala. (September 19, 2017) – Southern Cancer Center (SCC), a premier oncology clinic in Alabama and a practice in The US Oncology Network, is the first site in the world to open enrollment for a new clinical trial for newly diagnosed kidney cancer patients. This phase 3 clinical trial will look at various investigational […]

Read More

US Oncology Research plays an important role in the clinical development for NERLYNX (neratinib) tablets

September 12, 2017

NERLYNXTM is a new treatment option for early-stage HER2+ breast cancer patients following adjuvant trastuzumab-based therapy in the extended adjuvant setting The Woodlands, Texas (September 12, 2017) — Early-stage breast cancer patients with HER2-positive tumors now have a promising new anti-HER2 treatment option in the extended adjuvant setting, thanks in large part to the efforts […]

Read More

US Oncology Research and Epizyme Establish Collaboration to Identify Non-Hodgkin Lymphoma Patients with EZH2 Mutations

August 1, 2017

Eligible Patients to be Directed to Epizyme’s Ongoing Phase 2 Clinical Trial of Tazemetostat in Follicular Lymphoma and Diffuse Large B-cell Lymphoma THE WOODLANDS, Texas and CAMBRIDGE, Mass. (August 1, 2017) – Epizyme, Inc. (NASDAQ: EPZM), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, and US Oncology Research, one of the nation’s largest networks of […]

Read More